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Introduction: Ethambutol (ETB) is an antimycobacterial agent that is most commonly used
in combination with other drugs in the treatment of tuberculosis (TB). There is evidence
that the drug exerts its bacteriostatic activity by inhibition of the enzyme that is a constit-
uent of a mycobacterial cell wall. Studies have been shown that primary (pretreatment)
resistance rates of Mycobacterium tuberculosis (MTB) to ethambutol vary widely, i.e., from
1% to as high as 14%. In the present study, the aim is to investigate the percent of primary
resistance among new pulmonary TB cases.
Material and methods: One hundred sixty-five (n = 165) newly positive TB patients were
included in this study. The susceptibility and molecular typing were performed on all cul-
ture-positive isolates. Both nested allele-specific PCR and PCR-RLFP were used to identify
ETB resistant isolates.
Results: Out of 165 newly diagnosed patients, 145 (88%) were sensitive to all drugs tested. In
total, 20 drug-resistant isolates (13%) were detected by both methods. Four were MDR-TB
(3%) and the remaining were mono-drug resistant (10%). Only 6 isolates showed resistance
to ETB (4%).
Conclusion: The results showed a lower rate of ETB mono-drug resistance in Iran, but more
extensive studies are needed to get a clearer picture. Additionally, it was found out that the
molecular methods are useful tools to rapidly identify resistant isolates.
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